Nahoul K, Dehennin L, Jondet M, Roger M
Fondation de Recherche en Hormonologie, Fresnes, France.
Maturitas. 1993 May;16(3):185-202. doi: 10.1016/0378-5122(93)90064-o.
Doses of 100 mg of micronized progesterone (P) and of 0.5 mg of micronized estradiol (E2) were administered vaginally and orally, respectively, in the early follicular phase of the menstrual cycle in six premenopausal women. In the second cycle, the same doses were administered in the same subjects, orally for P and vaginally for E2. Serial blood samples were collected and the following steroids were assayed by highly reliable techniques: P, E2, estrone (E1), deoxycorticosterone (DOC), 5 alpha- and 5 beta-pregnanolone and the sulfates of E1, E2, and DOC. Circulating P and E2 levels were higher after vaginal than after oral administration, while those of E1 were similar after either route. Metabolites of P (DOC, DOCS and pregnanolone) were higher after oral administration. Concerning estrogen sulfates, E1S concentrations were similar whichever the route, while those of E2S were lower after oral than after vaginal administration. This study has confirmed that metabolism of ingested P and E2 occurs mainly in the intestine. Moreover, P was predominantly metabolized to 5 alpha-reduced derivatives, whatever the route of administration. In view of the metabolic pathways which are operative and of the peripheral plasma levels which were found, the vaginal route appears to be more adequate than the oral one for hormone replacement therapy.
在六个绝经前女性月经周期的卵泡早期,分别经阴道给予100毫克微粉化孕酮(P),经口服给予0.5毫克微粉化雌二醇(E2)。在第二个周期,对相同受试者给予相同剂量,P改为口服,E2改为经阴道给药。采集系列血样,并采用高度可靠的技术检测以下类固醇:P、E2、雌酮(E1)、脱氧皮质酮(DOC)、5α-和5β-孕烷醇酮以及E1、E2和DOC的硫酸盐。经阴道给药后循环中的P和E2水平高于口服给药后,而E1水平在两种给药途径后相似。口服给药后P的代谢产物(DOC、DOCS和孕烷醇酮)水平较高。关于雌激素硫酸盐,无论给药途径如何,E1S浓度相似,而口服给药后E2S浓度低于经阴道给药后。本研究证实,摄入的P和E2主要在肠道发生代谢。此外,无论给药途径如何,P主要代谢为5α-还原衍生物。鉴于起作用的代谢途径以及所发现的外周血水平,经阴道途径似乎比口服途径更适合激素替代疗法。